OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The autocrine regulation of insulin-like growth factor-1 in human brain of Alzheimer’s disease
Dali Kang, Henry J. Waldvogel, Ao Wang, et al.
Psychoneuroendocrinology (2021) Vol. 127, pp. 105191-105191
Closed Access | Times Cited: 9

Showing 9 citing articles:

Anthocyanins in Chronic Diseases: The Power of Purple
Sunil K. Panchal, Oliver D. John, Michael L. Mathai, et al.
Nutrients (2022) Vol. 14, Iss. 10, pp. 2161-2161
Open Access | Times Cited: 49

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Jie Miao, Yanli Zhang, Su Chen, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 6

Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline
Han Tong, Vladislav Petyuk, Michael Sendtner, et al.
Journal of Alzheimer s Disease (2025)
Closed Access

Effect of gastrodin against cognitive impairment and neurodegeneration in APP/PS1 mice via regulating gut microbiota–gut–brain axis
Yuhe Zhang, Chen Yan, Shushu Yuan, et al.
Experimental Brain Research (2023) Vol. 241, Iss. 6, pp. 1661-1673
Closed Access | Times Cited: 9

Role of the Insulin-like Growth Factor System in Neurodegenerative Disease
Moira Lewitt, Gary W. Boyd
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4512-4512
Open Access | Times Cited: 2

The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment
Yudi Wang, He Zhang, Xuehua Zhang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access

Neuropeptide cyclo-L-prolylglycine counteracts scopolamine-induced long-term memory impairment in rats in the novel object recognition test
O. N. Vorontsova, A. G. Alyaeva, Ксения Николаевна Колясникова, et al.
Pharmacokinetics and Pharmacodynamics (2023), Iss. 3, pp. 50-55
Open Access | Times Cited: 1

Neuroprotective Effect of the Neuropeptide Cycloprolylglycine Depends on AMPA- and TrkB-Receptor Activation
Т. А. Гудашева, Ксения Николаевна Колясникова, A. G. Alyaeva, et al.
Doklady Biochemistry and Biophysics (2022) Vol. 507, Iss. 1, pp. 264-267
Closed Access | Times Cited: 2

Page 1

Scroll to top